Axl-IN-19 (Compound 68) is a selective inhibitor of AXL, a membrane-bound receptor tyrosine kinase, with an IC50 of 5.3 nM and a cellular KD of 6.8 nM. In rats, Axl-IN-19 demonstrates favorable pharmacokinetic properties, featuring low clearance and moderate bioavailability, and is applicable for cancer research.
Molecular Weight:
507.63
CAS Number:
[2870696-46-9]
Formula:
C31H33N5O2
Target:
TAM Receptor
T207381
* VAT and and shipping costs not included. Errors and price changes excepted
